[Research Material] Global Market for Genetically Modified Protein Preparations

World Market for Recombinant Protein Preparations: Recombinant Protein Pharmaceuticals, Peptide Hormones, Vaccines, Therapeutic Enzymes, Monoclonal Antibodies ...

This research report (Global Bioengineered Protein Drugs Market) investigates and analyzes the current status and outlook for the global market of genetically engineered protein formulations over the next five years. It includes information on the overview of the global genetically engineered protein formulation market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the genetically engineered protein formulation market include recombinant protein pharmaceuticals, peptide hormones, vaccines, therapeutic enzymes, monoclonal antibodies, cytokines, alternative proteins, peptide antibiotics, and blood products. The segments by application include fractionation, bioreactor/microbial cell fermentation, genetic engineering, genetically modified organisms, farming, transgenic microorganism-derived bioengineering protein pharmaceuticals, plants and animals, cell culture, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, among others.

Other services